Low expression of bcl-2 in Brca1-associated breast cancers

British Journal of Cancer

Volumn 83, Issue 10, 2000, Pages 1318-1322

  Freneaux, P ^a   Stoppa Lyonnet, D ^a   Mouret, E ^a   Kambouchner, M ^a   Nicolas, A ^a   Zafrani, B ^a   Vincent Salomon, A ^a   Fourquet, A ^a   Magdelenat, H ^a   Sastre Garau, X ^a  

^a INSTITUT CURIE   (France)

Author keywords

Apoptosis; Bcl 2; Brca1; Brca2; Breast cancer; Proliferation

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; ESTROGEN RECEPTOR; PROTEIN BCL 2; PROTEIN P53;

ADULT; APOPTOSIS; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MITOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033749946     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1438     Document Type: Article

References (31)

1. Inherited BRCA2 mutation associated with high grade breast cancer
2. Survival in early-onse1 BRCA1-cancer patients
3. Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: A population-based study
4. Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity
5. bcl-2 and apoptosis in lymph node positive breast carcinoma
6. Studies on cell agony and death: An attempt at classification
7. Automated and quantitative immunocytochemical assays of Bcl-2 protein in breast carcinomas
8. p53 Mutations in BRCA 1-associated familiar breast cancer
9. Apoptosis
10. Biological studies in primary medical therapy of breast cancer: The Royal Marsden Hospital experience
11. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
12. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
13. Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy
14. Comparison of the respective prognostic values of Scarff-Bloom-Richardson and Nottingham histological grade in a series of 825 cases of breast cancer. Major importance of the mitotic count as a component of both grading systems
15. Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells
16. The molecular epidemiology of P53 gene mutations in human breast cancer
17. Prognostic value of bcl-2 expression in invasive breast cancer
18. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry
19. Histoprognostic grade in BRCA1-associated breast cancer
20. Bcl-2 protein expression and long-term survival in breast cancer
21. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations
22. bcl-2 in normal breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer
23. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry
24. BRCA-associated breast cancer: Absence of a characteristic immunophenotype
25. p53 Mutations in BRCA1-associated familial breast cancer
26. p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients
27. The Bcl-2 protein: A prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients
28. The p53 gene in breast cancer: Prognostic value of complementary DNA sequencing versus immunohistochemistry
29. Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, by also with increased proliferative activity
30. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation
31. BRCA1 and BRCA2 in breast cancer